Articles

  1. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, McNair N, Dandekar A, Razinia T, Kidwell CS. PROTECT- A coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 2004;63:1217-1222.
  2. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, Selco S, Rajajee V, McNair N, Razinia T, Kidwell CS. In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up. Stroke 2004;35:2879-2883.
  3. Fonarow G. C., Gawlinski A., Moughrabi S., Tillisch J. H. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 2001;87(7):819-22.
  4. Sacco RL, Benjamin EJ, Broderick JP, et al. Risk factors. Stroke 1997;28:1507-1517.
  5. Ferguson J. H. Curative and population medicine: bridging the great divide. Neuroepidemiology 1999;18(3):111-9.
  6. D'Agostino R. B., Wolf P. A., Belanger A. J., Kannel W. B. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke 1994;25(1):40-3.
  7. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997;349(9066):1641-9.
  8. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349(9065):1569-81.
  9. CAPRIE Steering Committee CAPRIE Investigators. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet 1996;348:1329-1339.
  10. Hass W. K., Easton J. D., Adams H. P., Jr., et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989;321(8):501-7.
  11. Diener H. C., Cunha L., Forbes C., et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143(1-2):1-13.
  12. Albers G. W., Dalen J. E., Laupacis A., et al. Antithrombotic therapy in atrial fibrillation. Chest 2001;119(1 Suppl):194S-206S.
  13. Stroke Prevention in Atrial fibrillation Investigators: Warfarin versus aspirin for prevention of thromboembolism in atrail fibrillation: Stroke Prevention in Atrial Fibrillation II study. Lancet 343:687, 1994.
  14. Stroke Prevention in Atrial fibrillation Investigators: Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 156:409, 1996.
  15. Atrial fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled adapted from five randomized controlled trials. Arch Intern Med 154:1449, 1994.
  16. Hart RG. Atrial fibrillation ands stroke: concepts and controversies. Stroke 2001;32:803-8
  17. Kool M. J., Hoeks A. P., Struijker Boudier H. A., et al. Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 1993;22(7):1881-6.
  18. Cruickshank J. M., Neil-Dwyer G., Dorrance D. E., et al. Acute effects of smoking on blood pressure and cerebral blood flow. J Hum Hypertens 1989;3(6):443-9.
  19. Goldstein L. B., Adams R., Becker K., et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001;32(1):280-99.
  20. Wolf P. A., D'Agostino R. B., Kannel W. B., et al. Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 1988;259(7):1025-9.
  21. Fletcher G. F. Exercise in the prevention of stroke. Health Rep 1994;6(1):106-10.
  22. Elkind M. S., Sacco R. L. Stroke risk factors and stroke prevention. Semin Neurol 1998;18(4):429-40.
  23. Williams P. T. High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med 1996;334(20):1298-303.
  24. Joshipura K. J., Ascherio A., Manson J. E., et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999;282(13):1233-9.
  25. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340(2):115-26.
  26. Rauch U, Osende J I, Fuster V, et al. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Annals of Internal Medicine 2001;134:224-238.
  27. Ansell B. J. Cholesterol, stroke risk, and stroke prevention. Curr Atheroscler Rep 2000;2(2):92-6.
  28. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
  29. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomized placebo-controlled trial.  Lancet 2002;  360: 7-22M.
  30. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. Stroke. 2002 Sep;33(9):2337-41.
  31. Burt V. L., Cutler J. A., Higgins M., et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26(1):60-9.
  32. MacMahon S., Peto R., Cutler J., et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335(8692):765-74.
  33. Rossi G., Rossi A., Sacchetto A., et al. Hypertensive cerebrovascular disease and the renin-angiotensin system. Stroke 1995;26(9):1700-6.
  34. Yusuf S., Sleight P., Pogue J., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [see comments] [published errata appear in N Engl J Med 2000 Mar 9;342(10):748 and 2000 May 4;342(18):1376]. N Engl J Med 2000;342(3):145-53.
  35. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358(9287):1033-41.
  36. Kothari R., Sauerbeck L., Jauch E., et al. Patients' awareness of stroke signs, symptoms, and risk factors. Stroke 1997;28:1871-5.
  37. Gage BF. CardinalliAB, Owens DK: The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. Arch Intern Med 156:1829, 1996.
  38. Kargman DE, Tuck C, Berglund L, Sacco R.: Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998;139:391-399.
  39. Samsa GP, Matchar DB, Goldstein L, Bonito A, Duncan PW, Lipscomb J, Enarson C, Witter D, Venus P, Paul JE, Weinberger M. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J. 1998 Oct;136(4 Pt 1):703-13.
  40. Wolf PA, Cobb JL, D'Agostino RB. Epidemiology of stroke. In Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke - Pathophysiology, Diagnosis, and Management. New York: Churchill Livingstone, 1992:3-27
  41. American Diabetes Association. Clinical practice recommendations 1998. Diabetes Care 1998;21 (Suppl 1):S1-S89
  42. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocyteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-1398
  43. PATS Collaborating Group. Post-stroke antihypertensive treatment study: a preliminary result. Chinese Med J 1995;108:710-717
  44. Appel LJ. The Verdict From ALLHAT-Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension. JAMA 2002; 288(23):3039-42

Guidelines/Consensus Statements

·         AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update (2002)

·         ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation (2001)

·         ATP III At-A-Glance: Quick Desk Reference (2001)

·         Antithrombotic therapy in atrial fibrillation (2001)

·         Sixth ACCP Consensus Conference on Antithrombotic Therapy

·         Antithrombotic and thrombolytic therapy for ischemic stroke (2001)

·         AHA Scientific Statements

Web design and graphics by Sharai Designs
© Copyright 2002. UCLA Stroke/Vascular Neurology program. All rights reserved.